| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |